Corvus Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:CRVS Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
11 Jun 26	BuyUS$250,236	David Moore	Individual		21,700	US$11.53
18 May 26	BuyUS$83,453	Richard Miller	Individual		6,932	US$12.05

Insider Trading Volume

Insider Buying: CRVS insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CRVS?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	1,188,103	1.41%
Individual Insiders	2,979,016	3.54%
VC/PE Firms	7,165,006	8.52%
General Public	9,481,654	11.3%
Institutions	63,276,645	75.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 70.43% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.52%	OrbiMed Advisors LLC	7,165,006	US$109.1m	0%	1.5%
7.33%	BlackRock, Inc.	6,160,422	US$93.8m	21.8%	no data
4.24%	State Street Global Advisors, Inc.	3,565,992	US$54.3m	27.9%	no data
3.9%	Adams Street Partners, LLC	3,275,616	US$49.9m	0%	13.75%
3.85%	Vanguard Capital Management, LLC	3,234,538	US$49.3m	0%	no data
3.47%	T. Rowe Price Group, Inc.	2,917,300	US$44.4m	8,450%	no data
3.34%	Vivo Capital, LLC	2,805,816	US$42.7m	25.6%	3.2%
2.96%	Deep Track Capital, LP	2,491,539	US$37.9m	0%	0.54%
2.96%	Morgan Stanley	2,490,448	US$37.9m	-30.2%	no data
2.77%	Richard Miller	2,331,742	US$35.5m	0.3%	no data
2.76%	Wellington Management Group LLP	2,318,517	US$35.3m	637%	0.01%
2.73%	Perceptive Advisors LLC	2,292,441	US$34.9m	231%	0.59%
2.69%	Commodore Capital LP	2,258,735	US$34.4m	0%	1.43%
2.18%	Foresite Capital Management, LLC	1,831,233	US$27.9m	32.6%	2.23%
2.08%	Braidwell LP	1,752,798	US$26.7m	0%	0.8%
2.04%	Geode Capital Management, LLC	1,712,741	US$26.1m	16.3%	no data
1.99%	MPM BioImpact LLC	1,674,875	US$25.5m	-39%	1.52%
1.6%	The Goldman Sachs Group, Inc.	1,345,336	US$20.5m	415%	0.01%
1.59%	Hood River Capital Management LLC	1,335,109	US$20.3m	0%	0.16%
1.41%	Miller-Horning Family Trust	1,188,103	US$18.1m	0%	no data
1.36%	Emerald Advisers, LLC	1,145,469	US$17.4m	0%	0.26%
1.31%	Boxer Capital Management, LLC	1,100,000	US$16.8m	0%	1.69%
1.27%	Polar Capital Holdings Plc	1,070,174	US$16.3m	0%	0.03%
1.06%	Catalio Capital Management, LP	891,933	US$13.6m	0%	2.73%
1.03%	Millennium Management LLC	866,362	US$13.2m	25.8%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/06 07:52
End of Day Share Price	2026/07/02 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Corvus Pharmaceuticals, Inc. is covered by 13 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Etzer Darout	Barclays
Dane Leone	BTIG
Li Wang Watsek	Cantor Fitzgerald & Co.